Who
Johan M. Spoor
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Perspective Therapeutics; President and CEO, GridAI Technologies; Director, MetaStat; CEO, President, Chairman, Fluoropharma Medical; Director, Protea Biosciences Group; Director, AtheroNova.
In numbers
- Trades disclosed
- 44
- Buys
- 11
- Sells
- 0
- Bought
- $424K
- Sold
- $0
- Companies
- 6
- Companies where not an officer
- 3
- First trade
- 18 Nov 2011
- Last trade
- 2 Mar 2026
- Last filed
- 4 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Mar 2026filed 4 Mar 2026 | CATX Perspective Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —735,000 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | CATX Perspective Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —735,000 at $0.00 | filing |
| 28 Mar 2025filed 1 Apr 2025 | CATX Perspective TherapeuticsBiotechnology | SEC FORM 4 Bought | $49K22,026 at $2.24 | filing |
| 28 Mar 2025filed 1 Apr 2025 | CATX Perspective TherapeuticsBiotechnology | SEC FORM 4 Bought | $10K4,650 at $2.21 | filing |
| 3 Mar 2025filed 5 Mar 2025 | CATX Perspective Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —650,000 at $0.00 | filing |
| 4 Dec 2024filed 4 Dec 2024 | CATX Perspective TherapeuticsBiotechnology | SEC FORM 4 Bought | $30K8,000 at $3.77 | filing |
| 25 Nov 2024filed 26 Nov 2024 | CATX Perspective TherapeuticsBiotechnology | SEC FORM 4 Bought | $55K14,500 at $3.78 | filing |
| 25 Nov 2024filed 26 Nov 2024 | CATX Perspective TherapeuticsBiotechnology | SEC FORM 4 Bought | $21K5,400 at $3.80 | filing |
| 25 Nov 2024filed 26 Nov 2024 | CATX Perspective TherapeuticsBiotechnology | SEC FORM 4 Bought | $25K6,600 at $3.80 | filing |
| 20 Jun 2024filed 24 Jun 2024 | CATX Perspective Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 13 Jun 2024filed 13 Jun 2024 | CATX Perspective TherapeuticsBiotechnology | SEC FORM 4 Bought | $117K100,000 at $1.17 | filing |
| 12 Dec 2023filed 14 Dec 2023 | CATX Perspective Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,338,878 at $0.00 | filing |
| 6 Apr 2020filed 7 Apr 2020 | GRDX GridAI Technologiesoption or derivative · Electric Utilities & IPPs | SEC FORM 4 Code A | —80,000 | filing |
| 28 Dec 2018filed 2 Jan 2019 | GRDX GridAI TechnologiesElectric Utilities & IPPs | SEC FORM 4 Bought | $50K38,583 at $1.30 | filing |
| 12 Jul 2018filed 16 Jul 2018 | GRDX GridAI TechnologiesElectric Utilities & IPPs | SEC FORM 4 Code A | —200,000 | filing |
| 10 Nov 2017filed 14 Nov 2017 | GRDX GridAI TechnologiesElectric Utilities & IPPs | SEC FORM 4 Code X | $100K100,000 at $1.00 | filing |
| 10 Nov 2017filed 14 Nov 2017 | GRDX GridAI Technologiesoption or derivative · Electric Utilities & IPPs | SEC FORM 4 Code X | —100,000 at $0.00 | filing |
| 3 Feb 2017filed 7 Feb 2017 | GRDX GridAI Technologiesoption or derivative · Electric Utilities & IPPs | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 18 May 2015filed 17 Jun 2015 | MetaStatoption or derivative | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 18 May 2015filed 20 May 2015 | MetaStatoption or derivative | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.